The Data is Positioned as the Great Challenge to Achieve Precision Medicine and end Cancer

Only in 2021 and only in our country, a total of 276,000 cases of cancer were diagnosed, according to the Spanish Society of Medical Oncology (SEOM), and it is estimated that 113,000 patients died due to this disease. It is not surprising, therefore, that both the research community and the public sector and companies are seeking, via innovation, how to eradicate cancer from our daily vocabulary. Nor is it trivial, following this reasoning, that this innovation is not limited solely to the medical or pharmacological field, but rather bet on multidisciplinarity and transversality. And it is that, as they say, to great challenges, great solutions.

On this subject he discussed meeting organized by the Carlos III University of Madrid together with FENIN (Spanish Federation of Health Technology Companies) this week. An appointment that served to put on the table the importance of collaboration between the different agents in the health sector and, specifically, to exploit the data in the fight against complex diseases such as cancer. After the pertinent welcome, in charge of Carlos Blanco, Vice Manager for Research and Transfer at UC3Mwould Margarita Alfonsel, Secretary General of FENINwho would introduce some of these concepts in the conversation.

“One of the great objectives passes for promoting a new value chain around health technology, which bet on R+D+I, the transfer of results and the creation of a new innovative business fabric with high added value”. In Alfonsel’s opinion, this collaboration should lead us to the “construction of a more modern, intelligent and sustainable health system” on the pillars of initiatives such as the Health Technology Innovation Platform, created in 2009, which has now evolved into a forum for startups.